Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     

  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     

  • Bitcoin GBP

    50,368.80
    +2,937.80 (+6.19%)
     

  • CMC Crypto 200

    1,359.39
    +82.41 (+6.45%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     

  • DAX

    18,001.60
    +105.10 (+0.59%)
     

  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     
MONEY:

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

New Strong Sell Stocks for March 15th

Zacks Equity Research
·1-min read

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Agilon Health, Inc. AGL is a healthcare services company for seniors. The Zacks Consensus Estimate for its current year earnings has been revised 357.1% downward over the last 60 days.

BankFinancial Corporation BFIN is a bank holding company for BankFinancial, National Association. The Zacks Consensus Estimate for its current year earnings has been revised 12.6% downward over the last 60 days.

Sleep Number Corporation SNBR offers sleep solutions and services. The Zacks Consensus Estimate for its current year earnings has been revised 155.7% downward over the last 60 days.

ADVERTISEMENT

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Agilon Health, Inc. (AGL) : Free Stock Analysis Report

BankFinancial Corporation (BFIN) : Free Stock Analysis Report

Sleep Number Corporation (SNBR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research